Etcembly Appoints Scott Cuthill as Chief Business Officer
Oxfordshire, UK, 15 March 2022 – Etcembly today announced the appointment of Scott Cuthill PhD, as Chief Business Officer (CBO). The Oxford based company is harnessing the power of the adaptive immune system to transform the precision, scale and speed of development of TCR immunotherapies.